Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers-Reference-Cited by-同舟云学术

Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers

Published:2011-08-11 Issue:6 Volume:118 Page:1498-1506
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Raghav Kanwal P. S.,Hernandez-Aya Leonel F.,Lei Xiudong,Chavez-MacGregor Marianan,Meric-Bernstam Funda,Buchholz Thomas A.,Sahin Aysegul,Do Kim-Anh,Hortobagyi Gabriel N.,Gonzalez-Angulo Ana M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.26431/fullpdf

Reference35 articles.

1. Molecular portraits of human breast tumours;Perou;Nature.,2000

2. American Society of Clinical Oncology. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer;Harris;J Clin Oncol.,2007

3. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Early Breast Cancer Trialists' Collaborative Group (EBCTCG);Lancet.,2005

4. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial;Arimidex;Lancet Oncol.,2008

5. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer;Romond;N Engl J Med.,2005

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reporting Hormone Receptor Expression in Breast Carcinomas: Which Method has the Highest Prognostic Power and What Should be the Optimal Cut-off Value?;International Journal of Surgical Pathology;2024-09-08

2. Designing a Collaborative Breast Radiology Training Program to Tackle Tanzania’s Breast Cancer Crisis;Journal of the American College of Radiology;2024-08

3. Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer;JNCI: Journal of the National Cancer Institute;2024-07-31

4. Real-world overall survival and characteristics of patients with ER-zero and ER-low HER2-negative breast cancer treated as triple-negative breast cancer: a Swedish population-based cohort study;The Lancet Regional Health - Europe;2024-05

5. Real-world data of HER2-negative early breast cancer patients treated with anthracycline and/or taxane regimens in Japan;Breast Cancer;2024-04-29